Variant report
Variant | nsv912509 |
---|---|
Chromosome Location | chr19:56367705-56379514 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:305)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CREB1 | chr19:56368555-56368853 | GM12878 | blood: | n/a | n/a |
2 | CTCF | chr19:56378429-56378458 | MCF-7 | breast: | n/a | n/a |
3 | CTCF | chr19:56373863-56373926 | Kidney_OC | kidney: | n/a | n/a |
4 | CTCF | chr19:56372755-56372812 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr19:56376627-56376650 | GM13976 | blood: | n/a | n/a |
6 | E2F4 | chr19:56376472-56376516 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | EP300 | chr19:56373530-56373857 | GM12878 | blood: | n/a | n/a |
8 | IRF4 | chr19:56368521-56368818 | GM12878 | blood: | n/a | n/a |
9 | MEF2A | chr19:56368609-56368882 | GM12878 | blood: | n/a | n/a |
10 | MEF2C | chr19:56368514-56368871 | GM12878 | blood: | n/a | n/a |
11 | MYC | chr19:56378495-56378699 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | MYC | chr19:56378438-56378522 | HUVEC | blood vessel: | n/a | n/a |
13 | MYC | chr19:56378530-56378566 | HUVEC | blood vessel: | n/a | n/a |
14 | POLR2A | chr19:56378395-56378419 | A549 | lung: | n/a | n/a |
15 | POLR2A | chr19:56378421-56378432 | A549 | lung: | n/a | n/a |
16 | POLR2A | chr19:56379491-56379597 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | SPI1 | chr19:56368477-56368789 | GM12878 | blood: | n/a | n/a |
18 | TCF12 | chr19:56368637-56368826 | GM12878 | blood: | n/a | n/a |
19 | ZBTB33 | chr19:56373591-56374116 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56369602-56369652 | HCT-116 | colon: | n/a |
2 | chr19:56369522-56369572 | PrEC | prostate: | n/a |
3 | chr19:56369522-56369572 | Hela-S3 | cervix: | n/a |
4 | chr19:56369416-56369466 | NHBE | bronchial: | n/a |
5 | chr19:56369928-56369978 | MCF-7 | breast: | n/a |
6 | chr19:56369416-56369466 | AG09309 | skin: | n/a |
7 | chr19:56369416-56369466 | HRPEpiC | eye: | n/a |
8 | chr19:56369416-56369466 | T-47D | breast: | n/a |
9 | chr19:56369602-56369652 | PFSK-1 | brain: | n/a |
10 | chr19:56369416-56369466 | IMR90 | lung: | fetal |
11 | chr19:56369416-56369466 | GM06990 | blood: | n/a |
12 | chr19:56369416-56369466 | RPTEC | kidney: | n/a |
13 | chr19:56367830-56367880 | GM06990 | blood: | n/a |
14 | chr19:56369522-56369572 | HEEpiC | esophagus: | n/a |
15 | chr19:56367830-56367880 | SKMC | muscle: | n/a |
16 | chr19:56367830-56367880 | T-47D | breast: | n/a |
17 | chr19:56369928-56369978 | ovcar-3 | ovarian: | n/a |
18 | chr19:56369522-56369572 | AG04449 | skin: | fetal |
19 | chr19:56369602-56369652 | BJ | skin: | n/a |
20 | chr19:56369602-56369652 | Hela-S3 | cervix: | n/a |
21 | chr19:56369416-56369466 | NH-A | brain: | n/a |
22 | chr19:56369416-56369466 | NT2-D1 | testis: | n/a |
23 | chr19:56367830-56367880 | HRCEpiC | kidney: | n/a |
24 | chr19:56369602-56369652 | HPAEpiC | pulmonary alveolar: | n/a |
25 | chr19:56369602-56369652 | HCPEpiC | choroid plexus: | n/a |
26 | chr19:56369522-56369572 | SK-N-MC | brain: | n/a |
27 | chr19:56369928-56369978 | SK-N-SH | brain: | n/a |
28 | chr19:56369602-56369652 | NT2-D1 | testis: | n/a |
29 | chr19:56369416-56369466 | BE2_C | brain: | n/a |
30 | chr19:56369522-56369572 | AG09319 | gingival: | n/a |
31 | chr19:56369928-56369978 | NB4 | blood: | n/a |
32 | chr19:56367830-56367880 | NB4 | blood: | n/a |
33 | chr19:56367830-56367880 | BE2_C | brain: | n/a |
34 | chr19:56369928-56369978 | HNPCEpiC | eye: | n/a |
35 | chr19:56369416-56369466 | AoSMC | blood vessel: | n/a |
36 | chr19:56367830-56367880 | HCM | heart: | n/a |
37 | chr19:56367830-56367880 | PrEC | prostate: | n/a |
38 | chr19:56369416-56369466 | HCF | heart: | n/a |
39 | chr19:56369416-56369466 | ProgFib | skin: | n/a |
40 | chr19:56369416-56369466 | Hela-S3 | cervix: | n/a |
41 | chr19:56369416-56369466 | Caco-2 | colon: | n/a |
42 | chr19:56369522-56369572 | HCT-116 | colon: | n/a |
43 | chr19:56367830-56367880 | HEEpiC | esophagus: | n/a |
44 | chr19:56369928-56369978 | GM12892 | blood: | n/a |
45 | chr19:56369602-56369652 | AG09309 | skin: | n/a |
46 | chr19:56369416-56369466 | HAEpiC | amniotic membrane: | n/a |
47 | chr19:56369522-56369572 | HCPEpiC | choroid plexus: | n/a |
48 | chr19:56367830-56367880 | U87 | brain: | n/a |
49 | chr19:56369416-56369466 | SKMC | muscle: | n/a |
50 | chr19:56369522-56369572 | HIPEpiC | eye: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NLRP4 | TF binding region |
NLRP4 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17710196 | chr19:56367705-56367706 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
2 | rs553189222 | chr19:56367706-56367707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544267002 | chr19:56367712-56367713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369464054 | chr19:56367727-56367728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148941243 | chr19:56367757-56367758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530191810 | chr19:56367759-56367760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376162561 | chr19:56367790-56367791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549205272 | chr19:56367794-56367795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190768189 | chr19:56367802-56367803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182101247 | chr19:56367848-56367849 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs143658473 | chr19:56367852-56367853 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs551680150 | chr19:56367871-56367872 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs568557408 | chr19:56367876-56367877 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs369587307 | chr19:56367877-56367878 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs71182923 | chr19:56367888-56367889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571434129 | chr19:56367914-56367915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374100637 | chr19:56367918-56367919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537064163 | chr19:56367923-56367924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs578012265 | chr19:56367926-56367927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550133193 | chr19:56367934-56367935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186822166 | chr19:56367942-56367943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535903755 | chr19:56367946-56367947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191659636 | chr19:56367963-56367964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573432339 | chr19:56367973-56367974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538836684 | chr19:56367975-56367976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559239689 | chr19:56367991-56367992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575816154 | chr19:56368007-56368008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76112228 | chr19:56368011-56368012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541030719 | chr19:56368019-56368020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs386811121 | chr19:56368027-56368028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146535253 | chr19:56368028-56368029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188320120 | chr19:56368029-56368030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560545963 | chr19:56368031-56368032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528320872 | chr19:56368039-56368040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141307507 | chr19:56368042-56368043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs36113692 | chr19:56368071-56368072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530669608 | chr19:56368073-56368074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370602158 | chr19:56368074-56368075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566964336 | chr19:56368081-56368082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561102872 | chr19:56368082-56368083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111608889 | chr19:56368087-56368088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376522467 | chr19:56368088-56368089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11882339 | chr19:56368094-56368095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113125142 | chr19:56368101-56368102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558858534 | chr19:56368104-56368105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575900013 | chr19:56368108-56368109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373901098 | chr19:56368126-56368127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374436947 | chr19:56368127-56368128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564837098 | chr19:56368145-56368146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs62128164 | chr19:56368160-56368161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56364600-56372200 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr19:56367400-56368200 | Enhancers | GM12878-XiMat | blood |
3 | chr19:56368200-56368800 | Weak transcription | GM12878-XiMat | blood |
4 | chr19:56368800-56369000 | Active TSS | GM12878-XiMat | blood |
5 | chr19:56369000-56369200 | Flanking Active TSS | GM12878-XiMat | blood |
6 | chr19:56369200-56369400 | Enhancers | GM12878-XiMat | blood |
7 | chr19:56369400-56370200 | ZNF genes & repeats | GM12878-XiMat | blood |